Autoimmune Disease and Mental Health: Why Mood and Fatigue Travel Together

Last reviewed: 07/28/2026

Reviewed by: Dr. Kiesa Kelly

If you live with lupus, rheumatoid arthritis, multiple sclerosis, Crohn's disease, or autoimmune thyroid disease, you have probably been on both ends of the same conversation. In one version, you mention feeling flat or unlike yourself, and someone says, "Well, of course — look at what you're dealing with." In the other, you describe a physical symptom that scares you, and someone says, "That's probably anxiety."

Both close a door. The first assumes your mood is untreatable because it is understandable; the second assumes your body is fine because your mind is struggling. Either one costs you: months of avoidable suffering, or a physical problem left uninvestigated.

The honest version is more useful. Mood and fatigue really do travel together here — partly for biological reasons, partly as a measurement artifact, and partly from the weight of living with an unpredictable body. Sorting those threads apart is what separates "this is just how it is now" from an actual plan, and it is the core of what health psychology for chronic illness is for.

In this article, you'll learn:

• What is established about inflammation and mood, and what is still hypothesis

• Why depression screeners can overcount depression in autoimmune conditions

• How diagnostic overshadowing harms people in both directions

• Which parts of the load have nothing to do with inflammation

• What psychological support does alongside medical care, and when to ask for it

Three things you may have been told that aren't quite right

"Feeling depressed with a chronic illness is just realistic, so there's nothing to treat"

Understandable and untreatable are not the same thing. Grief and frustration in response to illness are appropriate. A persistent loss of interest in everything, a collapse in self-worth, or a sense that nothing will ever be worth doing again are not proportionate reactions. Depression is more common in people with chronic disease, and it is treatable even when another illness is present [1].

"If inflammation is causing it, therapy can't do anything"

This sounds scientific, which makes it stickier, but cause and remedy are not the same axis. Depressive symptoms with an inflammatory contribution still respond to behavioral change and cognitive work — and the causal claim itself is far less settled than headlines suggest.

"Fatigue is a physical symptom, so a psychologist isn't relevant"

Fatigue in autoimmune disease is usually driven by the disease, and no one should tell you otherwise — we covered that trap in why low energy on a health screener isn't always "just stress". But disease-driven does not mean out of reach.

How activity is spread across a week, how sleep is timed, and how a bad day gets read all shape function, and they are what health psychology works on. It also matters that mood tools like the PHQ-9 ask directly about energy and sleep — which is where much of the confusion starts.

🧭 Key takeaway: Understandable does not mean untreatable, and physical does not mean out of reach. Those two assumptions keep more people stuck than any symptom does.

What we actually know about inflammation and mood

This is one of the most interesting areas in psychiatry, and one of the most overstated. It is worth being precise about which parts are settled.

What is well established

Depression occurs at higher rates in autoimmune populations than in the general population. In inflammatory bowel disease, a meta-analysis of 77 studies and more than 30,000 patients found symptoms of depression in about 25 percent and anxiety in about 32 percent [2]. In lupus, pooled estimates across 59 studies put major depression at 24 percent by clinical interview [3].

The relationship also runs both ways. In a British birth-cohort study, depression and autoimmune disorders co-occurred more often than chance would predict, and each raised the subsequent risk of the other [4]. A Swedish register study with a sibling comparison found roughly a 30 percent higher risk in each direction between autoimmune disease and perinatal depression, strongest for multiple sclerosis [5] — a pregnancy-specific population, so the numbers should not be generalized wholesale, but the two-way pattern matches the broader literature.

It is also established that inflammatory signaling can produce behavior that looks like depression. Cytokines released during an immune response act on the brain and generate what researchers call sickness behavior: withdrawal, low motivation, reduced appetite, slowed activity [6]. Anyone who has had the flu has felt a short version of it.

What is still hypothesis

Here is the part that gets flattened in popular coverage. The claim that inflammation causally drives depression in a given individual is a hypothesis under active investigation, not a settled finding. The leading review of this model frames it as applying to a subgroup of people with depression, not to depression as a whole [7]. No single cytokine works as a validated clinical biomarker you can test for and act on, and treatment trials are mixed: a 2024 meta-analysis of 48 studies found an antidepressant signal for anti-inflammatory agents overall, while noting that for one of the most-studied classes the efficacy was comparable to placebo [8]. Anti-inflammatory medication is not an established treatment for depression, and nothing here is a reason to change how your immunological disease is managed.

🔬 Key takeaway: "Inflammation is associated with depression" is well supported. "Inflammation causes your depression" is not something anyone can currently tell you about your own case.

Why fatigue and depression are so hard to tell apart

This is the most useful part of the picture, and the part most often skipped.

The measurement problem hiding inside depression screeners

Standard depression screeners ask about sleep, energy, appetite, concentration, and psychomotor slowing. In a healthy person, elevated scores there are meaningful. In someone with active autoimmune disease, the same items can be pushed up by the disease itself, independent of mood.

The effect is striking when one condition is measured several ways. In rheumatoid arthritis, a meta-analysis of 72 studies found major depressive disorder in 16.8 percent of patients — but by the PHQ-9 the figure was 38.8 percent, and by the HADS at a cutoff of 8, 34.2 percent [9]. Same population, more than a twofold difference by instrument. Lupus shows the same pattern: 24 percent by clinical interview, 30 percent by HADS, 39 percent by the Beck Depression Inventory [3].

That is not a flaw in the tools; they do what they were built to do, which is flag people who warrant a closer look. But here, a high score starts a conversation rather than ending one.

What a careful clinician does with a high score

The fix is not to discard the somatic items, which would undercount real depression. It is to look at which items drive the score. Elevation concentrated in energy, sleep, and appetite while mood, interest, and self-worth stay intact leans toward disease burden. Prominent anhedonia, worthlessness, guilt, and loss of anticipated pleasure lean toward depression no matter how much fatigue is present. A broader measure such as PROMIS-29 — physical function, pain, and fatigue alongside mood — helps show which.

📊 Key takeaway: In rheumatoid arthritis, measured depression more than doubles depending on the instrument. Ask what your score is actually measuring before you accept what it seems to say.

Diagnostic overshadowing runs in both directions

Diagnostic overshadowing is what happens when a symptom gets attributed to a condition already in the chart and then stops being investigated. It is a documented source of delayed diagnoses, avoidable harm, and lasting damage to trust [10]. Here it runs both ways.

When mood gets written off as part of the illness

Consider someone eighteen months into a Crohn's diagnosis whose inflammatory markers have finally normalized. She should feel relieved, and instead she feels almost nothing. She has stopped answering the friends who checked on her during the worst of it, and she sits in the car in the driveway for twenty minutes before going inside after work. At her follow-up she mentions she has been low, and gets a sympathetic nod and a comment that it has been a hard year. Nobody asks whether she has lost interest in what she used to care about, whether she feels worthless, or whether she has had thoughts of not wanting to be here. Her disease is in remission and her depression is untreated, filed under "understandable" and never examined.

When physical symptoms get written off as anxiety

Now consider someone in his thirties with a documented anxiety history who notices numbness in his left hand and a strange heaviness in one leg by late afternoon. He raises it at an urgent-care visit, and the intake note records his psychiatric history first. He is told stress causes a lot of physical sensations, offered breathing exercises, and sent home. He believes it, because he has heard a version of it before, and he stops bringing it up. Eight months later an unrelated MRI finds demyelinating lesions. The anxiety was real; it was not the explanation, and treating it as one cost him a year.

⚖️ Key takeaway: Both errors come from the same reflex — explaining a new symptom with a label already in the chart. New or changing physical symptoms deserve medical evaluation even when a mental health diagnosis is present.

The part of this that isn't inflammation at all

Some of this weight has no immunological explanation and does not need one. Flares do not schedule themselves, so planning becomes a negotiation with an unreliable partner, and you learn to under-commit as self-protection. There is also the loss of a former baseline — the version of you who could work a full day or say yes without calculating the recovery cost. That is a genuine grief, and it does not resolve just because the illness is well controlled. Our piece on adjusting after a chronic illness diagnosis sits with that part.

Medical trauma is also more common than most people expect. Frightening procedures, being disbelieved, and long stretches of undiagnosed symptoms can leave real trauma responses that make future care harder to tolerate; chronic illness and medical trauma covers when that is worth addressing directly.

Then there is the invisible-illness problem: looking fine while feeling terrible, and the constant labor of self-advocacy — tracking symptoms, preparing for appointments, correcting the record, asking again. None of that is a symptom. It is work, and it is exhausting.

🪫 Key takeaway: Grief, unpredictability, medical trauma, and advocacy fatigue are not side effects of inflammation. They are real psychological demands, and they respond to psychological support.

What health-psychology support does alongside medical care

To be explicit: autoimmune disease is a medical condition and is treated medically. Psychological support does not replace rheumatology, neurology, gastroenterology, or endocrinology, and no therapy adjusts an immunological treatment plan. The evidence marks that boundary clearly — a 2023 meta-analysis of psychological therapies in inflammatory bowel disease found meaningful short-term gains in anxiety, depression, stress, and quality of life, and no effect on disease activity [11].

Therapies adapted for an unpredictable body

Cognitive behavioral therapy for chronic illness targets the thought patterns that build up around a body you cannot predict: catastrophic reading of early flare signals, all-or-nothing activity rules, and the belief that resting once means surrendering permanently. Trials of cognitive behavioral approaches for fatigue in multiple sclerosis have shown reductions in fatigue severity [12]. Acceptance and commitment therapy takes a different angle — rather than arguing with distressing thoughts about your body, it builds the capacity to carry them while still moving toward what matters. When symptoms will not fully resolve, that shift often beats chasing symptom reduction, and ACT for chronic illness is one of the approaches we use for it.

Energy, sleep, and the shape of a week

Pacing breaks the boom-and-bust cycle, where a good day gets overspent and the next three are lost, by distributing activity on a planned quota rather than by how you feel. Sleep work matters alongside it: disrupted sleep amplifies both pain and mood, and it is often one of the few levers still movable when disease activity is not.

Grief, adjustment, and talking to your medical team

Adjustment and grief work give the losses somewhere to go, instead of letting them leak into every appointment. Communication is also a skill: describing a symptom so it registers, asking for a specific investigation, raising mood without letting it absorb the whole visit. Our specialized therapy work often includes rehearsing that.

One thing belongs with your prescriber rather than in an article: corticosteroids are recognized to have mood effects, and a 2024 systematic review found depressive symptoms in about 22 percent of glucocorticoid users [13]. That is not a reason to change or stop anything — dosing decisions belong to the prescribing physician — but raise it if your mood shifted around a steroid course.

When to raise mood with your medical team versus seeking a psychological evaluation

Here is a heuristic you can apply before you leave this page.

• If the physical picture has changed, start with your medical team: new or worsening fatigue, a suspected flare, new neurological symptoms, a recent medication change including steroids, or labs you have not discussed. Mood that moves in step with disease activity — worse in a flare, better in remission — points toward the disease.

• If the physical picture is stable and the mood picture is not, start with a psychological evaluation. Your disease is well managed, yet interest, motivation, self-worth, or hopelessness have shifted and stayed shifted for two weeks or more. Our mental health screening tools are a place to start orienting.

• If both are true, do both. These are not competing referrals, and each answer sharpens the other.

• If you are having thoughts of harming yourself, escalate immediately: call or text 988, or go to your nearest emergency room.

For a clinician who works at the intersection of physical and mental health, Hannah Pollok focuses on the psychology of chronic illness — the coping, the grief, the day-to-day adjustment.

🤝 Key takeaway: If mood tracks with disease activity, chase the disease. If mood drifted while the disease held steady, chase the mood. If you cannot tell, that ambiguity is itself a reason to be assessed rather than to wait.

Where that leaves you

The tension we started with was a false choice between "it's just the illness" and "it's just anxiety." The evidence supports neither. Depression really is more common here; the mechanisms are partly understood and partly still hypothesis; our screening tools overlap with the illness in ways that require interpretation; and much of the psychological load has nothing to do with immune biology at all.

None of that is a diagnosis you can make for yourself. It is a set of better questions for the people already treating you — and the knowledge that treating your mood is not a distraction from treating your disease. It runs alongside it.

Feeling weighed down lately?

Depression is treatable, and the right support makes a difference — a clinician can help you understand what's going on and what would help you feel like yourself again.

Schedule a depression consultation →

Frequently Asked Questions

Can an autoimmune disease actually cause depression?

Not in a simple one-to-one way, and the causal question is genuinely unsettled. What is established is that depression is much more common in autoimmune conditions than in the general population, and that markers of inflammation are often elevated in people with depression. Whether inflammation directly drives low mood in any one person is still being studied. Either way, the depression is real, and it responds to treatment.

Why do depression screeners score higher in people with autoimmune illness?

Because several screener items ask about symptoms your illness can produce on its own: fatigue, disrupted sleep, appetite change, and slowed movement. In rheumatoid arthritis, the measured rate of depression shifts dramatically with the tool used, from roughly 17 percent by diagnostic criteria to closer to 39 percent by the PHQ-9. A high score is a reason to look more closely, not a diagnosis by itself.

Should I tell my medical team about my mood, or find a therapist first?

Start with your medical team if anything physical has changed: new or worsening fatigue, a suspected flare, new neurological symptoms, or a recent medication change. Start with a psychological evaluation if your disease is stable but your mood, motivation, hopelessness, or sense of self-worth have shifted. If both are true, do both. They are not competing, and each answer sharpens the other.

Can therapy reduce inflammation or change my autoimmune disease?

There is no good evidence that psychological therapy changes the disease process itself. A 2023 meta-analysis of psychological therapies in inflammatory bowel disease found short-term improvements in anxiety, depression, stress, and quality of life, but no effect on disease activity. Therapy runs alongside medical treatment rather than replacing it, and no one should stop or change a prescribed medication because of it.

My fatigue is physical, so how could a psychologist help with it?

Fatigue that starts in the body still has a daily pattern you can work with. Health psychology targets the parts that respond to changed behavior: how activity is spread across a week, boom-and-bust cycles, sleep timing, and what you conclude about yourself on a bad day. None of that says your fatigue is psychological. It addresses the layer that behavior reaches while your medical team treats the disease.

About the Author

Dr. Kiesa Kelly is a licensed clinical psychologist and the founder of ScienceWorks Behavioral Healthcare. Her background includes more than 20 years of experience in psychological assessment and evidence-based treatment, with particular depth in differential diagnosis — the work of distinguishing conditions whose symptoms overlap, which is precisely the problem that arises when mood, fatigue, and physical illness present together.

Dr. Kelly's clinical training includes work at the University of Chicago, Vanderbilt University, and the University of Wisconsin, along with NIH-funded research training. She is a psychologist, not a physician, and does not diagnose or treat immunological disease; her clinical work addresses the psychological dimensions of living with a chronic condition, alongside the medical care that treats it.

References

1. National Institute of Mental Health. Understanding the Link Between Chronic Disease and Depression. https://www.nimh.nih.gov/health/publications/chronic-illness-mental-health

2. Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(5):359–370. https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00014-5/fulltext

3. Zhang L, Fu T, Yin R, Zhang Q, Shen B. Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis. BMC Psychiatry. 2017;17:70. https://link.springer.com/article/10.1186/s12888-017-1234-1

4. Euesden J, Danese A, Lewis CM, Maughan B. A bidirectional relationship between depression and the autoimmune disorders — new perspectives from the National Child Development Study. PLoS One. 2017;12(3):e0173015. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0173015

5. Bränn E, et al. Bidirectional association between autoimmune disease and perinatal depression: a nationwide study with sibling comparison. Mol Psychiatry. 2024. https://www.nature.com/articles/s41380-023-02351-1

6. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46–56. https://www.nature.com/articles/nrn2297

7. Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22–34. https://www.nature.com/articles/nri.2015.5

8. Du Y, Dou Y, Wang M, et al. Efficacy and acceptability of anti-inflammatory agents in major depressive disorder: a systematic review and meta-analysis. Front Psychiatry. 2024;15:1407529. https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2024.1407529/full

9. Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2013;52(12):2136–2148. https://academic.oup.com/rheumatology/article/52/12/2136/1800940

10. Shefer G, Henderson C, Howard LM, Murray J, Thornicroft G. Diagnostic overshadowing and other challenges involved in the diagnostic process of patients with mental illness who present in emergency departments with physical symptoms — a qualitative study. PLoS One. 2014;9(11):e111682. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0111682

11. Riggott C, Mikocka-Walus A, Gracie DJ, Ford AC. Efficacy of psychological therapies in people with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(10):919–931. https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00186-3/fulltext

12. Cognitive behavioural therapy for fatigue in patients with multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord. 2024. https://www.sciencedirect.com/science/article/pii/S221103482400484X

13. Koning ASCAM, van der Meulen M, Schaap D, et al. Neuropsychiatric adverse effects of synthetic glucocorticoids: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2024;109(6):e1442–e1451. https://academic.oup.com/jcem/article/109/6/e1442/7457344

Disclaimer

This article is for informational purposes only and is not a substitute for medical or mental health diagnosis, evaluation, or treatment. Autoimmune conditions are medical conditions and require medical care; nothing here should be used to self-diagnose an autoimmune disease, to interpret your own symptoms in place of a clinical evaluation, or to start, stop, or adjust any medication. Medication decisions, including those involving corticosteroids, immunosuppressants, and biologics, belong to the physician who prescribes them. Reading this article does not create a therapist-client relationship with ScienceWorks Behavioral Healthcare. If you are in crisis or may be at risk of harm to yourself or others, call 911, go to your nearest emergency room, or call or text 988 in the United States.